Jay F. Sarthy

发表

Automated in situ chromatin profiling efficiently resolves cell types and gene regulatory programs

James M. Olson, Steven Henikoff, Kami Ahmad, 2018, Epigenetics & Chromatin.

Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.

Emily J. Girard, J. Olson, R. Gottardo, 2020, Neuro-oncology.

Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma.

R. Ermoian, C. Lockwood, N. Vitanza, 2020, The journal of applied laboratory medicine.

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes

Michael P. Meers, S. Henikoff, G. Ha, 2022, bioRxiv.

Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia

Michael P. Meers, S. Henikoff, S. Meshinchi, 2020, Nature Genetics.

Apollo-taking the lead in telomere protection.

P. Baumann, Jay F. Sarthy, 2010, Molecular cell.

Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones

Patrick J. Paddison, Michael P. Meers, S. Henikoff, 2020, bioRxiv.

Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma.

Niklas Krumm, Angela Steineck, A. Stacey, 2019, JCO precision oncology.

Endolymphatic exclusion for the treatment of pediatric chylous ascites secondary to neuroblastoma resection: report of two cases

E. Monroe, J. Chick, Jay F. Sarthy, 2020, Radiology case reports.

Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype.

G. Wertheim, T. Olson, S. Meshinchi, 2018, Blood advances.

Acute enlargement of a vascular plaque and gait changes in a young girl

Jay F. Sarthy, K. Tedesco, M. Boos, 2018, British Medical Journal.

Single-cell analysis of chromatin silencing programs in developmental and tumor progression

Hatice S. Kaya-Okur, S. Henikoff, Anoop P. Patel, 2020, bioRxiv.

Chromatin Bottlenecks in Cancer.

S. Henikoff, K. Ahmad, Jay F. Sarthy, 2019, Trends in cancer.

Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression

Hatice S. Kaya-Okur, S. Henikoff, Anoop P. Patel, 2021, Nature Biotechnology.

dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region

H. Ruohola-Baker, R. D. Hawkins, Justin Decarreau, 2022, Cell reports.

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Heather L. Mulder, Michael P. Meers, Shondra M. Pruett-Miller, 2018, Nature Communications.

Automated in situ profiling of chromatin modifications resolves cell types and gene regulatory programs

Michael P. Meers, S. Henikoff, J. Olson, 2018, bioRxiv.

Mechanisms of Telomere Protection and Deprotection in Human Cells

Jay F. Sarthy, 2011 .

Human RAP1 inhibits non‐homologous end joining at telomeres

P. Baumann, Jay F. Sarthy, Nancy S. Bae, 2009, The EMBO journal.

Short H2A histone variants are expressed in cancer

S. Henikoff, R. Bradley, G. Chew, 2021, Nature Communications.

CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target

B. Hadland, I. Bernstein, K. Loeb, 2022, The Journal of clinical investigation.

HOXD13 is a direct EWS-FLI1 target and moderates fusion-dependent transcriptional states

S. Furlan, M. Ljungman, S. D. Taylor, 2022, bioRxiv.

Pediatric 8p11 eosinophilic myeloproliferative syndrome (EMS): A case report and review of the literature

M. Radhi, Jay F. Sarthy, K. Chastain, 2017, Pediatric blood & cancer.

EWS-FLI1 and HOXD13 control tumor cell plasticity in Ewing sarcoma.

S. Furlan, M. Ljungman, Feinan Wu, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

CBFA2T3-GLIS2 oncogenic fusion is sufficient for leukemic transformation

B. Hadland, I. Bernstein, K. Loeb, 2021 .

Bringing Oncohistones into the Fold.

S. Henikoff, Jay F. Sarthy, 2019, Cancer discovery.

Pyogenic liver abscess caused by Streptococcus mitis.

Jay F. Sarthy, D. Dibardino, 2013, The Lancet. Infectious diseases.

Chromatin Profiling of CBFA2T3-GLIS2 AMLs Identifies Key Transcription Factor Dependencies and BRG1 Inhibition as a Novel Therapeutic Strategy

S. Henikoff, R. Ries, S. Meshinchi, 2023, bioRxiv.

Human RAP1 inhibits non‐homologous end joining at telomeres

P. Baumann, Jay F. Sarthy, Nancy S. Bae, 2009, The EMBO journal.

A light scattering assay for arachidonic acid-induced tau fibrillization without interfering micellization.

Jay F. Sarthy, T. C. Gamblin, 2006, Analytical biochemistry.

G1 length dictates heterochromatin landscape

Laura A. Banaszynski, Jay F. Sarthy, Sara Martire, 2023, bioRxiv.

Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks.

C. Correnti, V. Voillet, Vishaka Muhunthan, 2024, Immunity.

Automated Parallel Oocyte Electrophysiology Test station (POETs): a screening platform for identification of ligand-gated ion channel modulators.

D. Mckenna, C. Shieh, M. Gopalakrishnan, 2003, Assay and drug development technologies.

KMT2A oncoproteins induce epigenetic resistance to targeted therapies

C. Mullighan, S. Meshinchi, K. Ahmad, 2023, bioRxiv.